CClinicalTrials.gg
Status unknownNCT03149367Updated May 11, 2017

Surgical Management of Blepharoptosis

An interventional study of levator muscle resection with fixed sutures technique and Levator muscle resection with adjustable sutures technique in Blepharoptosis, sponsored by Assiut University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2017-05-11.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2017), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

Comparison of the results of levator resection operation with the use of fixed sutures technique in which the levator muscle is approached through skin incision and the muscle shortened and sutured directly to the tarsus then the skin crease reformed with interrupted sutures which pick up the underlying levator muscle versus the results with the use of adjustable sutures in which the suture passes through the levator muscle into the tarsal plate and out through the skin edge .the skin crease is formed separately so that adjusting the suture doesn't open the wound, the suture can be adjusted according to the result up to 4 days post operative.

02

Conditions studied

  • Blepharoptosis

Browse trials for

03

In context

Blepharoptosis

58 studies on the registry are indexed under Blepharoptosis; 16 are open to participants now.

This study's planned enrollment of 40 is below the median of 46 across 47 interventional studies indexed under Blepharoptosis.

Browse Blepharoptosis studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Cases of blepharoptosis admitted at Assiut University Hospital.
  • Cases that are fit for surgery.

Exclusion criteria

Exclusion criteria:

  • Cases not fit for surgery.
  • Cases of pseudoptosis may result from many conditions that simulate an asymmetry of the upper eyelid level. Dysthyroid ophthalmopathy, enophthalmos, or exophthalmos can accentuate a minimal blepharoptosis or produce the appearance of blepharoptosis on the contralateral normal side,
  • Cases with diseases, such as myasthenia gravis; negativity for Bell palsy symptoms; and Marcus Gunn jaw-winking syndrome.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Fixed suture

    Procedure: levator muscle resection with fixed sutures technique

  • Experimental
    Adjustable suture

    Procedure: Levator muscle resection with adjustable sutures technique

Interventions

  • Procedurelevator muscle resection with fixed sutures technique

    The levator muscle is approached through skin incision and the muscle shortened and sutured directly to the tarsus then the skin crease reformed with interrupted sutures which pick up the underlying levator muscle

  • ProcedureLevator muscle resection with adjustable sutures technique

    The adjustable sutures technique in which the sutures passes through the levator muscle into the tarsal plate and out through the skin edge .the skin crease is formed separately so that adjusting the suture doesn't open the wound, the suture can be adjusted according to the result up to 4 days post operative.

06

What researchers measure

Primary outcomes

  1. The cosmetic appearance

    Symmetry of the two eyelids was calculated based on the difference in the margin reflex distance between them in the primary position of gaze. The results were classified into good, fair, and poor

    Time frame: One week

07

Study locations

1 site
  • Assuit university hospital
    Assuit, 71515, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03149367
Lead sponsor
Assiut University
Responsible party
Noha Ali Essameldeen Mohamed Ali (principle investigator, Assiut University) — Principal investigator
First posted
May 11, 2017
Start date
Mar 1, 2017
Primary completion
Mar 1, 2019 (estimated)
Completion
Sep 1, 2019 (estimated)
Last update
May 11, 2017

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion